Your browser is no longer supported. Please, upgrade your browser.
Settings
DERM Dermira, Inc. daily Stock Chart
DERM [NASD]
Dermira, Inc.
Index- P/E- EPS (ttm)-5.27 Insider Own0.30% Shs Outstand50.24M Perf Week-0.70%
Market Cap573.24M Forward P/E- EPS next Y-4.79 Insider Trans-18.85% Shs Float50.24M Perf Month-12.16%
Income-221.50M PEG- EPS next Q-1.49 Inst Own78.30% Short Float12.98% Perf Quarter79.12%
Sales42.30M P/S13.55 EPS this Y29.50% Inst Trans7.68% Short Ratio3.04 Perf Half Y-10.72%
Book/sh-0.21 P/B- EPS next Y15.30% ROA-50.70% Target Price21.88 Perf Year27.91%
Cash/sh6.23 P/C1.83 EPS next 5Y- ROE-310.80% 52W Range6.00 - 15.48 Perf YTD58.69%
Dividend- P/FCF- EPS past 5Y-39.30% ROI-70.10% 52W High-26.29% Beta1.40
Dividend %- Quick Ratio8.50 Sales past 5Y- Gross Margin97.20% 52W Low90.19% ATR1.10
Employees333 Current Ratio8.70 Sales Q/Q69.20% Oper. Margin- RSI (14)46.38 Volatility7.03% 7.04%
OptionableYes Debt/Eq- EPS Q/Q-26.80% Profit Margin- Rel Volume0.58 Prev Close11.15
ShortableYes LT Debt/Eq- EarningsMay 28 AMC Payout- Avg Volume2.15M Price11.41
Recom1.90 SMA20-12.30% SMA509.33% SMA20013.61% Volume1,250,392 Change2.33%
Mar-25-19Reiterated Needham Buy $16 → $22
Feb-22-19Initiated SVB Leerink Outperform $20
Feb-14-19Initiated H.C. Wainwright Buy $13
Jan-17-19Upgrade Raymond James Underperform → Mkt Perform
Nov-20-18Resumed Guggenheim Buy $20
Mar-06-18Downgrade Guggenheim Buy → Neutral
Mar-05-18Downgrade Mizuho Buy → Neutral $39 → $9
Mar-05-18Downgrade Mizuho Buy → Neutral
Dec-12-17Reiterated Mizuho Buy $43 → $39
Dec-06-17Initiated Guggenheim Buy $30
Nov-07-17Reiterated Needham Buy $46 → $43
Jun-30-17Initiated Evercore ISI Outperform $48
May-25-17Reiterated Mizuho Buy $42 → $40
Mar-31-17Initiated Mizuho Buy $42
Mar-16-17Initiated Raymond James Underperform
Jun-02-16Reiterated Needham Buy $42 → $46
May-11-16Reiterated Needham Buy $38 → $42
Jan-08-16Reiterated Needham Buy $33 → $38
Dec-18-15Upgrade Citigroup Neutral → Buy
Aug-17-15Reiterated Needham Buy $23 → $33
Apr-17-19 09:15AM  NASDAQ Back Above 8,000 Zacks -6.23%
Apr-08-19 05:06PM  Here's Why Dermira Shot Up 62% in March Motley Fool
Apr-03-19 04:05PM  Dermira to Present at the 18th Annual Needham Healthcare Conference Business Wire +5.59%
Apr-01-19 02:09PM  Does The Dermira, Inc. (NASDAQ:DERM) Share Price Fall With The Market? Simply Wall St.
Mar-25-19 12:00AM  Dermira Announces Life Unfolds Direct-to-Consumer Campaign to Highlight QBREXZA (glycopyrronium) Cloth GlobeNewswire +7.01%
Mar-22-19 04:01PM  Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Mar-20-19 10:28AM  Dermira (DERM) Catches Eye: Stock Jumps 12% Zacks
Mar-19-19 07:36PM  Dermira Prices $130.0 Million Public Offering of Common Stock GlobeNewswire +12.05%
04:00PM  Why Dermira Stock Jumped Again Today Motley Fool
10:52AM  Company News For Mar 19, 2019 Zacks
06:06AM  Can Dermira Stock Keep Soaring? Motley Fool
Mar-18-19 05:58PM  Edited Transcript of DERM earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents +84.36%
04:30PM  Dermira Announces Proposed Public Offering of Common Stock GlobeNewswire
12:48PM  Stocks making the biggest moves midday: Facebook, Deutsche Bank, Lumber Liquidators & more CNBC
12:31PM  Dermira News: Why DERM Stock Is Skyrocketing Today InvestorPlace
12:14PM  Why Dermira's Shares Are Doubling Today Motley Fool
11:15AM  Dermira Investors Get 100% One-Day Payoff a Year After Acne Flop Bloomberg
10:00AM  Dermira Shares Rocket After Successful Phase II Eczema Treatment Study TheStreet.com
09:53AM  Why Dermira Shares Are Shooting Higher After Last Year's Disappointment Benzinga
07:24AM  Dermira shares soar 83% premarket on news of positive trial of dermatitis treatment MarketWatch
07:00AM  Dermira Announces Positive Topline Results from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis GlobeNewswire
Mar-05-19 04:00PM  Dermira to Present at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Mar-01-19 08:51AM  Implied Volatility Surging for Dermira (DERM) Stock Options Zacks
08:00AM  Dermira Presents New Data from its Phase 3 Clinical Program Evaluating Glycopyrronium Tosylate (QBREXZA (glycopyrronium) cloth) in Patients with Primary Axillary Hyperhidrosis GlobeNewswire
Feb-26-19 04:01PM  Dermira Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Dermira Inc to Host Earnings Call ACCESSWIRE
08:00AM  Dermira to Present New Analyses of the Glycopyrronium Tosylate Clinical Program at the 77th American Academy of Dermatology Annual Meeting GlobeNewswire
Feb-22-19 08:00AM  Dermira Initiates Proof-of-Concept Study to Evaluate QBREXZA (glycopyrronium) Cloth in Patients with Primary Palmar Hyperhidrosis GlobeNewswire +13.30%
Feb-21-19 04:01PM  Dermira to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire -5.23%
Feb-19-19 04:01PM  Dermira to Report Fourth Quarter 2018 Results and Host Conference Call on Tuesday, February 26, 2019 GlobeNewswire
Feb-12-19 02:00AM  Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab GlobeNewswire +6.46%
Jan-08-19 12:50PM  At biotech's big event, a chance for execs to shape LGBTQ diversity on boards American City Business Journals
Dec-18-18 10:28PM  Do Hedge Funds Love Dermira Inc (DERM)? Insider Monkey -6.12%
Dec-11-18 05:07PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Dec-05-18 02:58PM  Is Dermira Incs (NASDAQ:DERM) CEO Paid At A Competitive Rate? Simply Wall St.
Dec-04-18 07:30AM  Dermira Enters into Credit Facility with Athyrium Capital Management GlobeNewswire
Nov-28-18 08:40AM  Report: Exploring Fundamental Drivers Behind CASI Pharmaceuticals, Booking, Enstar Group, Madrigal Pharmaceuticals, Dermira, and Kaiser Aluminum New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-19-18 08:00AM  Dermira to Present at Evercore ISI HealthCONx Conference GlobeNewswire
Nov-09-18 11:27AM  Edited Transcript of DERM earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -11.11%
Nov-08-18 04:05PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Nov-07-18 07:00PM  Dermira (DERM) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:01PM  Dermira Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-31-18 04:01PM  Dermira to Report Third Quarter 2018 Results and Host Conference Call on Wednesday, November 7, 2018 GlobeNewswire
Oct-23-18 04:01PM  Dermira Completes Patient Enrollment in Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis GlobeNewswire
Oct-17-18 07:25AM  Report: Exploring Fundamental Drivers Behind Dermira, California Resources, OGE Energy, Oasis Petroleum, Harmonic, and CBIZ New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-09-18 04:01PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Oct-02-18 08:30AM  Dermira and Christian Siriano Collaborate to Inspire People Living with Excessive Underarm Sweating to Feel Confident in Their Own Skin GlobeNewswire
Oct-01-18 07:30AM  Dermiras QBREXZA (glycopyrronium) Cloth Is Now Available in Pharmacies Nationwide for the Treatment of Primary Axillary Hyperhidrosis GlobeNewswire +6.88%
Sep-25-18 08:00AM  Dermira to Present at Cantor 2018 Global Healthcare Conference GlobeNewswire
Sep-13-18 06:00AM  Dermira Presents New Pediatric Efficacy and Safety Data for Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis at the European Academy of Dermatology and Venereology Congress GlobeNewswire
Sep-10-18 04:02PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Sep-05-18 07:30AM  Dermira Provides Launch Readiness Update for QBREXZA (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis GlobeNewswire +5.91%
Aug-20-18 07:50AM  Report: Exploring Fundamental Drivers Behind MediciNova, Dermira, FRP, BiondVax Pharmaceuticals, The Descartes Systems Group, and American Software New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-08-18 08:14PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-06-18 06:05PM  Dermira (DERM) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:02PM  Dermira: 2Q Earnings Snapshot Associated Press
04:01PM  Dermira Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Jul-10-18 04:01PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +5.47%
Jul-06-18 02:36PM  Dermira (DERM) Gains 5% in a Week, Post-Qbrexa Approval Zacks +7.60%
Jul-02-18 08:36AM  Are Options Traders Betting on a Big Move in Dermira (DERM) Stock? Zacks
Jun-29-18 12:00PM  Dermira Shares Soar With FDA Approval of New Cloth TheStreet.com
11:38AM  FDA OKs first drug made to reduce excessive sweating Associated Press
08:36AM  FDA approves Dermira's wipe for excessive armpit sweating Reuters
07:05AM  Dermira's treatment for excessive armpit sweating gets U.S. approval Reuters
07:00AM  Dermira Receives FDA Approval for Qbrexza (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis GlobeNewswire
Jun-18-18 07:20AM  Free Daily Technical Summary Reports on Dermira and Three Other Biotech Stocks ACCESSWIRE
Jun-08-18 04:01PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jun-05-18 08:30AM  Investor Expectations to Drive Momentum within Dermira, Atlassian, 51job, Sierra Wireless, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, and InterDigital Discovering Underlying Factors of Influence GlobeNewswire
May-31-18 08:07AM  Dermira, Upcoming FDA Decision on NDA, Analyst Review and Target ACCESSWIRE
May-30-18 04:01PM  Dermira to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
07:00AM  Wired News - Reata Pharma Presented Encouraging Interim Data from PHOENIX Trial Assessing Bardoxolone Methyl in Patients with ADPKD and IgA Nephropathy ACCESSWIRE
May-24-18 04:18PM  Here's Why Dermira Inc Stock Fell More Than 23% Today Motley Fool -22.61%
May-14-18 02:10PM  Schlumberger Is Among 7 Stocks Ready to Change Direction TheStreet.com +10.25%
08:30AM  Dermira to Host Analyst & Investor Day on May 24, 2018 GlobeNewswire
May-08-18 04:03PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-03-18 05:58PM  Dermira: 1Q Earnings Snapshot Associated Press
04:02PM  Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-02-18 08:00AM  Dermira and Cameran Eubanks Team Up to Raise Awareness of Excessive Sweating for the 15 Million People Living with the Condition in the U.S. GlobeNewswire
May-01-18 04:02PM  Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference GlobeNewswire
Apr-19-18 04:04PM  Christopher Horan Joins Dermira as Chief Technical Operations Officer GlobeNewswire
Apr-12-18 07:11PM  Will Dermira Incs (NASDAQ:DERM) Earnings Grow In The Years Ahead? Simply Wall St.
08:20AM  Recent Analysis Shows Landmark Infrastructure Partners LP, Laureate Education, MDC Partners, Pzena Investment Management, Dermira, and MediciNova Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Apr-11-18 04:05PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Mar-20-18 08:00AM  Dermira to Present at 17th Annual Needham Healthcare Conference GlobeNewswire
Mar-15-18 08:30AM  Market Trends Toward New Normal in Silver Standard Resources, Dermira, Colliers International Group, Canadian Pacific Railway, The Descartes Systems Group, and Westport Fuel Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -9.45%
Mar-14-18 07:30AM  Wired News Merrimack Expanded Enrollment in Ongoing Randomized Phase-2 SHERLOC Trial of MM-121 in Non-Small Cell Lung Cancer ACCESSWIRE
Mar-09-18 09:09AM  Your first trade for Friday, March 9 CNBC
07:45AM  Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails Zacks
Mar-08-18 04:05PM  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire -5.05%
08:00AM  Dermira to Present at Cowen & Company 38th Annual Healthcare Conference GlobeNewswire
Mar-06-18 10:36AM  Dermira's Acne Candidate Fails in Pivotal Trials, Shares Sink Zacks +10.59%
08:33AM  Dermira shares drop 66% after surprise acne clinical trial failure MarketWatch
08:30AM  Todays Research Reports on Trending Tickers: Akorn and Dermira ACCESSWIRE
07:20AM  Heres What Really Just Happened With Dermira, Inc. (NASDAQ:DERM) Market Exclusive
Mar-05-18 04:54PM  Why Dermira, Community Health Systems, and BRF Slumped Today Motley Fool -65.86%
04:13PM  Why This Biotech Stock Just Lost Two-Thirds Of Its Value Investor's Business Daily
03:07PM  US Stocks Reverse Losses GuruFocus.com
01:03PM  Here's Why Dermira Fell as Much as 64.2% Today Motley Fool
12:55PM  Dermira Inc Stock Plunges on Acne Drug Failure InvestorPlace
11:24AM  Dermira Reminds Investors What Binary Means in Biotech Bloomberg
Dermira, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with dermatologic diseases in the United States. The company offers QBREXZA, a topical once-daily anticholinergic cloth for the treatment of primary axillary hyperhidrosis in adult and pediatric patients nine years of age and older. It also develops lebrikizumab, a novel injectable humanized monoclonal antibody targeting interleukin 13 that is in Phase IIb clinical trial for the treatment of moderate-to-severe atopic dermatitis; and early-stage research and development programs in other areas of dermatology. Dermira, Inc. has a right of first negotiation agreement with Maruho Co., Ltd. to develop and commercialize glycopyrronium tosylate for the treatment of hyperhidrosis in Japan; an agreement with F. Hoffmann-La Roche Ltd and Genentech, Inc. to develop and commercialize lebrikizumab; and a development and commercialization agreement with UCB Pharma S.A. to develop Cimzia for the treatment of psoriasis. The company was formerly known as Skintelligence, Inc. and changed its name to Dermira, Inc. in September 2011. Dermira, Inc. was founded in 2010 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAUER EUGENE AChief Medical OfficerApr 08Option Exercise1.2235,00042,63043,900Apr 09 04:40 PM
BAUER EUGENE AChief Medical OfficerApr 08Sale15.0035,000525,0008,900Apr 09 04:40 PM
Fust Matthew KDirectorOct 19Sale13.754,00055,00014,051Oct 19 04:24 PM
BAUER EUGENE AChief Medical OfficerAug 15Option Exercise0.006,01209,831Aug 17 04:05 PM
GUGGENHIME ANDREWCOO and CFOAug 15Option Exercise0.008,075019,290Aug 17 04:05 PM
Griffith Christopher M.SVP Head Corp. Dev. & StrategyAug 15Option Exercise0.002,835047,043Aug 17 04:05 PM
WIGGANS THOMAS GCEO & Chairman of the BoardAug 15Option Exercise0.0020,5000100,010Aug 17 04:05 PM
Lyons-Williams LoriChief Commercial OfficerAug 15Option Exercise0.001,06302,984Aug 17 04:05 PM
Pena Luis C.Chief Development OfficerAug 15Option Exercise0.006,500017,047Aug 17 04:06 PM
WIGGANS THOMAS GCEO & Chairman of the BoardJul 09Buy10.0012,000119,95179,510Jul 09 06:57 PM
WIGGANS THOMAS GCEO & Chairman of the BoardJul 02Buy8.7113,780119,99867,510Jul 02 05:04 PM
WIGGANS THOMAS GCEO & Chairman of the BoardJun 25Buy9.8412,150119,58653,730Jun 25 05:40 PM
WIGGANS THOMAS GCEO & Chairman of the BoardJun 18Buy10.1011,875119,95441,580Jun 18 04:19 PM
Nunn Jason RaleighDirectorJun 13Option Exercise0.003,00003,000Jun 14 06:06 PM
MCDADE MARKDirectorJun 13Option Exercise0.003,00003,000Jun 14 05:45 PM
Cohen David EDirectorJun 13Option Exercise0.003,000032,682Jun 14 05:45 PM
Fust Matthew KDirectorJun 13Option Exercise0.003,000018,051Jun 14 05:45 PM
Sebelius KathleenDirectorJun 13Option Exercise0.003,00003,000Jun 14 05:45 PM
CRAVES FRED BDirectorJun 13Option Exercise0.003,00003,000Jun 14 05:46 PM
RINGO WILLIAM RDirectorJun 13Option Exercise0.003,00003,000Jun 14 05:45 PM
WIGGANS THOMAS GCEO & Chairman of the BoardMay 15Option Exercise0.9910,0009,86029,705May 16 06:43 PM